Tag: in-vitro lung model market growth

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

In-Vitro Lung Model Market Growth From $0.65 Billion In 2026 To $1.28 Billion By 2030 At A CAGR Of 18.6%

The in-vitro lung model market has experienced substantial growth in recent years. It will grow from $0.54 billion in 2025 to $0.65 billion in 2026 at a compound annual growth rate (CAGR) of 21.0%. This historical growth can be attributed to several factors, including the limitations of animal models in respiratory research, the persistent use of two-dimensional lung cell cultures, escalating respiratory disease research activity, an expansion in academic lung biology research, and the early adoption of organoid-based research methods.

The in-vitro lung model market size is anticipated to see substantial growth in the upcoming years. It is projected to expand to $1.29 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. The growth expected during this forecast period is attributable to the increasing demand for predictive preclinical lung models, a heightened focus on minimizing animal testing, the expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Key trends in the forecast period encompass the increasing adoption of three-dimensional lung models in drug research, the growing use of lung-on-a-chip platforms for disease modeling, a rising preference for human-relevant in-vitro lung testing systems, the expansion of in-vitro lung models in toxicology and safety studies, and a greater integration of in-vitro lung models into preclinical research pipelines.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=83973013&type=smp&name=In-Vitro%20Lung%20Model%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In-Vitro Lung Model Market Growth Drivers: What’s Behind The Acceleration?

The projected expansion of the in vitro lung model market is linked to the growing volume of clinical studies. These studies involve investigations aimed at assessing the safety, efficacy, and results of novel treatments, pharmaceuticals, and diagnostic instruments in human subjects. The surge in clinical investigations stems from evolving healthcare requirements, a heightened desire for advanced medical interventions, and the quest for innovative approaches to intricate health issues. The in vitro lung model market provides critical support for clinical research by supplying regulated environments conducive to drug assessment, toxicity analysis, disease representation, and the examination of lung-specific biological reactions. As an illustration, in January 2024, ClinicalTrials.gov, a US-based clinical trial registry, reported 477,230 registered clinical trials worldwide by the close of 2023, marking a rise from the 437,508 trials documented in 2022. Consequently, the increasing prevalence of clinical studies is a significant impetus for the in vitro lung model market.

In-Vitro Lung Model Market Segments: Where Is Growth Concentrated?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

In-Vitro Lung Model Market Trends: What’s Defining The Industry’s Next Phase?

Major companies within the in vitro lung model market are prioritizing the development of advanced 3D respiratory tissue models. This initiative aims to enhance their physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model describes a three-dimensional structure cultivated in a laboratory setting, comprising primary or specialized respiratory cells grown in conditions that allow them to mimic the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. As an example, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal. This innovation is a 3D respiratory tissue model constructed from primary human nasal epithelial cells, which replicates functional features of nasal epithelium such as goblet cells, active tight junctions, and beating cilia. It provides researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

In-Vitro Lung Model Market Key Participants And Competitive Landscape

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

View The Full In-Vitro Lung Model Market Report:

https://thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In-Vitro Lung Model Market Leading Geography: Which Region Contributes The Most Revenue?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

In-Vitro Lung Model Market Growth From $0.65 Billion In 2026 To $1.28 Billion By 2030 At A CAGR Of 18.6%

The in-vitro lung model market has experienced substantial growth in recent years. It will grow from $0.54 billion in 2025 to $0.65 billion in 2026 at a compound annual growth rate (CAGR) of 21.0%. This historical growth can be attributed to several factors, including the limitations of animal models in respiratory research, the persistent use of two-dimensional lung cell cultures, escalating respiratory disease research activity, an expansion in academic lung biology research, and the early adoption of organoid-based research methods.

The in-vitro lung model market size is anticipated to see substantial growth in the upcoming years. It is projected to expand to $1.29 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. The growth expected during this forecast period is attributable to the increasing demand for predictive preclinical lung models, a heightened focus on minimizing animal testing, the expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Key trends in the forecast period encompass the increasing adoption of three-dimensional lung models in drug research, the growing use of lung-on-a-chip platforms for disease modeling, a rising preference for human-relevant in-vitro lung testing systems, the expansion of in-vitro lung models in toxicology and safety studies, and a greater integration of in-vitro lung models into preclinical research pipelines.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=83973013&type=smp&name=In-Vitro%20Lung%20Model%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In-Vitro Lung Model Market Growth Drivers: What’s Behind The Acceleration?

The projected expansion of the in vitro lung model market is linked to the growing volume of clinical studies. These studies involve investigations aimed at assessing the safety, efficacy, and results of novel treatments, pharmaceuticals, and diagnostic instruments in human subjects. The surge in clinical investigations stems from evolving healthcare requirements, a heightened desire for advanced medical interventions, and the quest for innovative approaches to intricate health issues. The in vitro lung model market provides critical support for clinical research by supplying regulated environments conducive to drug assessment, toxicity analysis, disease representation, and the examination of lung-specific biological reactions. As an illustration, in January 2024, ClinicalTrials.gov, a US-based clinical trial registry, reported 477,230 registered clinical trials worldwide by the close of 2023, marking a rise from the 437,508 trials documented in 2022. Consequently, the increasing prevalence of clinical studies is a significant impetus for the in vitro lung model market.

In-Vitro Lung Model Market Segments: Where Is Growth Concentrated?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

In-Vitro Lung Model Market Trends: What’s Defining The Industry’s Next Phase?

Major companies within the in vitro lung model market are prioritizing the development of advanced 3D respiratory tissue models. This initiative aims to enhance their physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model describes a three-dimensional structure cultivated in a laboratory setting, comprising primary or specialized respiratory cells grown in conditions that allow them to mimic the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. As an example, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal. This innovation is a 3D respiratory tissue model constructed from primary human nasal epithelial cells, which replicates functional features of nasal epithelium such as goblet cells, active tight junctions, and beating cilia. It provides researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

In-Vitro Lung Model Market Key Participants And Competitive Landscape

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

View The Full In-Vitro Lung Model Market Report:

https://thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In-Vitro Lung Model Market Leading Geography: Which Region Contributes The Most Revenue?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

In-Vitro Lung Model Market Growth From $0.65 Billion In 2026 To $1.28 Billion By 2030 At A CAGR Of 18.6%

The in-vitro lung model market has experienced substantial growth in recent years. It will grow from $0.54 billion in 2025 to $0.65 billion in 2026 at a compound annual growth rate (CAGR) of 21.0%. This historical growth can be attributed to several factors, including the limitations of animal models in respiratory research, the persistent use of two-dimensional lung cell cultures, escalating respiratory disease research activity, an expansion in academic lung biology research, and the early adoption of organoid-based research methods.

The in-vitro lung model market size is anticipated to see substantial growth in the upcoming years. It is projected to expand to $1.29 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. The growth expected during this forecast period is attributable to the increasing demand for predictive preclinical lung models, a heightened focus on minimizing animal testing, the expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Key trends in the forecast period encompass the increasing adoption of three-dimensional lung models in drug research, the growing use of lung-on-a-chip platforms for disease modeling, a rising preference for human-relevant in-vitro lung testing systems, the expansion of in-vitro lung models in toxicology and safety studies, and a greater integration of in-vitro lung models into preclinical research pipelines.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=83973013&type=smp&name=In-Vitro%20Lung%20Model%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In-Vitro Lung Model Market Growth Drivers: What’s Behind The Acceleration?

The projected expansion of the in vitro lung model market is linked to the growing volume of clinical studies. These studies involve investigations aimed at assessing the safety, efficacy, and results of novel treatments, pharmaceuticals, and diagnostic instruments in human subjects. The surge in clinical investigations stems from evolving healthcare requirements, a heightened desire for advanced medical interventions, and the quest for innovative approaches to intricate health issues. The in vitro lung model market provides critical support for clinical research by supplying regulated environments conducive to drug assessment, toxicity analysis, disease representation, and the examination of lung-specific biological reactions. As an illustration, in January 2024, ClinicalTrials.gov, a US-based clinical trial registry, reported 477,230 registered clinical trials worldwide by the close of 2023, marking a rise from the 437,508 trials documented in 2022. Consequently, the increasing prevalence of clinical studies is a significant impetus for the in vitro lung model market.

In-Vitro Lung Model Market Segments: Where Is Growth Concentrated?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

In-Vitro Lung Model Market Trends: What’s Defining The Industry’s Next Phase?

Major companies within the in vitro lung model market are prioritizing the development of advanced 3D respiratory tissue models. This initiative aims to enhance their physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model describes a three-dimensional structure cultivated in a laboratory setting, comprising primary or specialized respiratory cells grown in conditions that allow them to mimic the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. As an example, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal. This innovation is a 3D respiratory tissue model constructed from primary human nasal epithelial cells, which replicates functional features of nasal epithelium such as goblet cells, active tight junctions, and beating cilia. It provides researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

In-Vitro Lung Model Market Key Participants And Competitive Landscape

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

View The Full In-Vitro Lung Model Market Report:

https://thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In-Vitro Lung Model Market Leading Geography: Which Region Contributes The Most Revenue?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

In-Vitro Lung Model Market Size, Value And Growth Trends Through 2030

The market for in-vitro lung models has seen substantial expansion over the last few years. Its value is projected to climb from $0.54 billion in 2025 to $0.65 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.0%. This past growth has been driven by factors such as the shortcomings of animal models in respiratory studies, the traditional reliance on two-dimensional lung cell cultures, a rise in research focused on respiratory diseases, an increase in academic investigations into lung biology, and the early integration of organoid-based research techniques.

The market for in-vitro lung models is projected to experience substantial expansion over the coming years. By 2030, its value is anticipated to reach $1.29 billion, reflecting a compound annual growth rate (CAGR) of 18.6%. This upward trajectory during the forecast period is driven by several key factors, including a growing need for predictive preclinical lung models, a heightened emphasis on minimizing animal testing, an expanding pipeline for respiratory drug development, increased funding for sophisticated in-vitro research tools, and a demand for lung disease models that more accurately mimic physiological conditions. Among the prominent trends shaping this period are the wider adoption of three-dimensional lung models in drug discovery, the increased utilization of lung-on-a-chip platforms for modeling diseases, a shift toward human-relevant in-vitro lung testing systems, the broader application of these models in toxicology and safety assessments, and their deeper integration into preclinical research workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

In-Vitro Lung Model Market Development Factors: Which Trends Are Supporting Demand?

The rising number of clinical studies is anticipated to drive growth in the in vitro lung model market moving forward. Clinical studies are research investigations designed to assess the safety, efficacy, and results of new medical treatments, drugs, or diagnostic tools in human subjects. This increase in clinical studies is fueled by expanding healthcare demands, a growing need for advanced therapeutic options, and the search for innovative approaches to address complex health issues. The in vitro lung model market facilitates clinical research by providing controlled environments that allow for drug testing, toxicity assessments, disease modeling, and the examination of lung-specific biological processes. As an example, in January 2024, ClinicalTrials.gov, a clinical trial registry based in the United States, reported that 477,230 clinical trials were registered worldwide by the end of 2023, up from 437,508 in 2022. Consequently, the surge in clinical studies is propelling the in vitro lung model market forward.

In-Vitro Lung Model Market Segment Landscape: Which Areas Lead Market Development?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

In-Vitro Lung Model Market Transformation Trends: Which Innovations Are Driving Change?

Leading players in the in vitro lung model industry are prioritizing the creation of advanced three-dimensional respiratory tissue constructs to boost physiological accuracy, refine predictive capabilities, and augment preclinical testing effectiveness. A 3D respiratory tissue construct is a laboratory-engineered, three-dimensional configuration cultivated from primary or dedicated respiratory cells under conditions that enable them to imitate the structure and operation of human airway tissues, including mucus secretion, ciliary action, and barrier function. As an example, in April 2023, MatTek Corporation, a biotechnology firm headquartered in the United States, launched EpiNasal, a 3D respiratory tissue construct derived from primary human nasal epithelial cells. This model reproduces functional characteristics of nasal epithelium, such as goblet cells, robust tight junctions, and beating cilia, offering scientists a relevant platform to assess the impact of medications, chemical substances, pathogens, and consumer goods on respiratory tissues.

In-Vitro Lung Model Market Industry Leaders And Market Competition

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Access The Complete In-Vitro Lung Model Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

In-Vitro Lung Model Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The In-Vitro Lung Model Market Become By 2030 Compared To 2026?

The in-vitro lung model market has experienced substantial expansion recently. It is forecast to rise from $0.54 billion in 2025 to $0.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.0%. Historically, this growth has been driven by factors such as the limitations of animal models in respiratory investigations, the long-standing use of two-dimensional lung cell cultures, heightened research activity in respiratory diseases, an increase in academic lung biology research, and the initial adoption of organoid-based research techniques.

The in-vitro lung model market is projected to experience significant growth over the coming years, with its size anticipated to reach $1.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. This expansion during the forecast period is driven by factors such as an increasing need for predictive preclinical lung models, a growing emphasis on reducing animal testing, the broadening of respiratory drug development pipelines, rising investments in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Prominent trends for the upcoming period include the increasing adoption of three-dimensional lung models in drug research, the expanding application of lung-on-a-chip platforms for disease modeling, a rising preference for human-relevant in-vitro lung testing systems, the wider use of in-vitro lung models in toxicology and safety studies, and greater integration of these models into preclinical research pipelines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Influential Factors Are Boosting The In-Vitro Lung Model Market Demand?

The expansion of clinical studies is projected to drive the future growth of the in vitro lung model market. These studies are defined as research inquiries carried out to assess the safety, efficacy, and results of novel medical interventions, pharmaceuticals, or diagnostic instruments in human subjects. The volume of clinical studies is escalating because of evolving healthcare requirements, a heightened need for sophisticated medical therapies, and the ongoing search for inventive remedies for intricate health issues. The in vitro lung model sector facilitates clinical research by providing regulated environments that allow for pharmaceutical testing, assessment of toxicity, disease simulation, and examination of biological reactions specific to the lungs. As an illustration, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated in January 2024 that a total of 477,230 clinical trials were registered worldwide by the close of 2023, which represents an increase from the 437,508 trials documented in 2022. Consequently, the expansion in clinical investigations is fueling the in vitro lung model market.

How Is The In-Vitro Lung Model Market Distributed Across Key Segments?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Trends Are Shaping The In-Vitro Lung Model Market Landscape?

Leading companies operating within the in vitro lung model market are prioritizing the development of advanced 3D respiratory tissue models to improve their physiological relevance, enhance predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model represents a three-dimensional structure grown in a laboratory, made up of primary or specialized respiratory cells cultivated in conditions that allow them to mimic the architecture and function of human airway tissues, encompassing aspects such as mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, a 3D respiratory tissue model created from primary human nasal epithelial cells. This model replicates functional features of nasal epithelium, including goblet cells, active tight junctions, and beating cilia, providing researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Firms Contributing To The In-Vitro Lung Model Market Ecosystem?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Access The Complete In-Vitro Lung Model Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Regional Market Leads The In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access In-Vitro Lung Model Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The In-Vitro Lung Model Market Compare Between 2026 And 2030?

The in-vitro lung model market has experienced significant expansion in recent years. This market is anticipated to grow from $0.54 billion in 2025 to $0.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.0%. The growth observed in the past can be ascribed to factors such as the limitations inherent in animal models for respiratory research, the consistent utilization of two-dimensional lung cell cultures, an increase in research activities related to respiratory diseases, the progression of academic lung biology research, and the early adoption of organoid-based research methodologies.

The in-vitro lung model market is poised for significant expansion in the coming years. Projections indicate it will reach $1.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.6%. This anticipated growth during the forecast period stems from several factors, including a surging need for predictive preclinical lung models, a heightened emphasis on minimizing animal testing, the broadening of respiratory drug development pipelines, increased capital expenditure in sophisticated in-vitro research instruments, and the requirement for more physiologically accurate lung disease models. Key trends anticipated during this period encompass the wider embrace of three-dimensional lung models in pharmaceutical research, the expanding application of lung-on-a-chip platforms for simulating diseases, a growing inclination towards human-relevant in-vitro lung assessment systems, the extended use of in-vitro lung models in toxicology and safety evaluations, and enhanced incorporation of these models into preclinical research workflows.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Leading Drivers Are Supporting The In-Vitro Lung Model Market Expansion?

The in vitro lung model market is expected to experience future growth, primarily driven by an increase in clinical studies. Clinical studies involve research investigations conducted to evaluate the safety, effectiveness, and outcomes of new medical treatments, drugs, or diagnostic tools in humans. The rising number of these studies is a result of growing healthcare needs, an increased demand for advanced medical treatments, and the ongoing pursuit of innovative solutions for complex health conditions. The in vitro lung model market provides essential support for clinical research by offering controlled systems that enable drug testing, toxicity evaluation, disease modeling, and the analysis of lung-specific biological responses. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,230 registered clinical trials globally by the end of 2023, representing an increase from the 437,508 trials recorded in 2022. Thus, the expansion of clinical studies is significantly propelling the in vitro lung model market.

What Segment Categories Shape The In-Vitro Lung Model Market Segment Landscape?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Trends Are Affecting The Direction Of The In-Vitro Lung Model Market?

Major companies operating in the in vitro lung model market are actively developing advanced 3D respiratory tissue models, aiming to enhance their physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model refers to a three-dimensional structure grown in a laboratory, composed of primary or specialized respiratory cells cultured in conditions that enable them to mimic the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal. This 3D respiratory tissue model, created from primary human nasal epithelial cells, replicates functional features of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, thereby providing researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Companies Operating Across The In-Vitro Lung Model Market Value Chain?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Get The Full In-Vitro Lung Model Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Holds The Highest Market Share In The In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized In-Vitro Lung Model Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The In-Vitro Lung Model Market During The Forecast Period 2026–2030?

The in-vitro lung model market size has experienced significant growth in recent years. This market is projected to expand from $0.54 billion in 2025 to $0.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 21.0%. Historically, this growth can be ascribed to several factors, including the limitations of animal models in respiratory research, the longstanding reliance on two-dimensional lung cell cultures, increasing activity in respiratory disease research, a surge in academic lung biology research, and the early adoption of organoid-based research methodologies.

The in-vitro lung model market is projected for significant expansion in the coming years, reaching a valuation of $1.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. This anticipated growth during the forecast period is driven by several factors, including a heightened demand for predictive preclinical lung models, a stronger emphasis on minimizing animal testing, the broadening of respiratory drug development pipelines, increased investment in sophisticated in-vitro research instruments, and the need for more physiologically relevant lung disease models. Key trends anticipated over this period encompass the wider acceptance of three-dimensional lung models in pharmaceutical research, the expanding application of lung-on-a-chip platforms for disease modeling, an increasing preference for human-relevant in-vitro lung testing solutions, the broader utilization of in-vitro lung models in toxicology and safety assessments, and their enhanced integration into preclinical research pipelines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Underlying Factors Are Accelerating The Growth Of The In-Vitro Lung Model Market?

A projected expansion of the in vitro lung model market is anticipated, driven by the rising number of clinical studies. These studies are research investigations performed to assess the safety, efficacy, and results of novel medical treatments, pharmaceuticals, or diagnostic instruments in human subjects. The growing volume of clinical studies stems from escalating healthcare requirements, a heightened need for sophisticated medical interventions, and the quest for groundbreaking answers to intricate health issues. The in vitro lung model market aids clinical research through the provision of controlled systems facilitating drug screening, toxicity assessment, disease simulation, and the examination of biological responses specific to the lungs. As an illustration, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated in January 2024 that a total of 477,230 clinical trials were registered worldwide by the close of 2023, showing an increase from the 437,508 trials documented in 2022. Consequently, the expansion in clinical studies acts as a primary catalyst for the in vitro lung model market.

What Market Segments Are Evaluated Within The In-Vitro Lung Model Market?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Industry Trends Are Redefining The In-Vitro Lung Model Market?

Leading companies in the in vitro lung model market are concentrating on developing sophisticated 3D respiratory tissue models to boost physiological accuracy, enhance predictive precision, and reinforce preclinical testing capabilities. A 3D respiratory tissue model represents a laboratory-cultivated three-dimensional structure composed of primary or specialized respiratory cells grown in conditions that allow them to replicate the architecture and function of human airway tissues, including mucus generation, ciliary motion, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, which is a 3D respiratory tissue model developed from primary human nasal epithelial cells that mimics functional aspects of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, thereby providing researchers with a highly pertinent platform for assessing the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Top Market Participants Influencing The In-Vitro Lung Model Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Read the full in-vitro lung model market report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Is Projected To Dominate The In-Vitro Lung Model Market During The Forecast Period?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored In-Vitro Lung Model Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the in-vitro lung model market from 2026–2035 with trusted insights from The Business Research Company

How much is the In-Vitro Lung Model Market valued at in 2026, and what valuation is forecast for 2030?

The in-vitro lung model market has experienced substantial expansion in recent years. It is projected to grow from $0.54 billion in 2025 to $0.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.0%. This market’s historical growth can be attributed to several factors, including the limitations of animal models in respiratory research, the longstanding use of two-dimensional lung cell cultures, a rise in respiratory disease research activity, the expansion of academic lung biology research, and the early adoption of organoid-based research methods.

The in-vitro lung model market is anticipated to experience substantial growth over the next few years. It is forecast to expand to $1.29 billion by 2030, achieving a compound annual growth rate (CAGR) of 18.6%. This projected growth stems from several factors, including an increasing need for predictive preclinical lung models, a heightened focus on reducing animal experimentation, the expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, and the demand for more physiologically relevant lung disease models. Prominent trends throughout the forecast period include the increasing incorporation of three-dimensional lung models in drug research, the rising utilization of lung-on-a-chip platforms for disease modeling, a growing preference for human-relevant in-vitro lung testing systems, the broadening application of in-vitro lung models in toxicology and safety studies, and greater integration of these models into preclinical research pipelines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Drivers Are Influencing The Growth Of The In-Vitro Lung Model Market?

The expanding volume of clinical investigations is anticipated to fuel the future expansion of the in vitro lung model market. These studies represent scientific inquiries carried out to assess the security, efficacy, and results of novel medical therapies, pharmaceuticals, or diagnostic instruments in human subjects. The escalating count of clinical studies stems from increasing healthcare requirements, a heightened desire for sophisticated medical interventions, and the quest for pioneering remedies for intricate health issues. The in vitro lung model market facilitates clinical research through the provision of regulated platforms that facilitate drug screening, toxicity assessment, disease simulation, and the examination of biological responses specific to the lungs. As an illustration, in January 2024, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated that 477,230 clinical trials were registered globally by the end of 2023, which signifies an increment from the 437,508 trials documented in 2022. Consequently, the uptick in clinical studies serves as a primary impetus for the in vitro lung model market.

How Is The In-Vitro Lung Model Market Organized Into Various Segments?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Trends Are Influencing The Development Of The In-Vitro Lung Model Market?

Leading companies in the in vitro lung model market are concentrating on developing advanced 3D respiratory tissue models to enhance physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model is defined as a laboratory-grown three-dimensional structure comprising primary or specialized respiratory cells cultured in environments that enable them to emulate the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, a 3D respiratory tissue model developed from primary human nasal epithelial cells that mimics functional aspects of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, offering researchers a highly pertinent platform for assessing the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Major Companies Operating In The In-Vitro Lung Model Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized In-Vitro Lung Model Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the sarcoma drugs market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Sarcoma Drugs Market Be Worth By 2029, And What CAGR Will It Achieve?

The in-vitro lung model market has experienced significant growth in its size recently. It is anticipated to expand from $0.44 billion in 2024 to reach $0.54 billion in 2025, demonstrating a robust compound annual growth rate (CAGR) of 21.0%. The expansion observed in prior periods is attributable to the increasing incidence of respiratory conditions, a heightened focus on personalized medicine, a rising interest in drug repurposing, an emphasis on precision medicine approaches, and greater public awareness of environmental health risks.

The in-vitro lung model market size is projected to experience substantial growth in the upcoming years, expanding to $1.11 billion by 2029, at a compound annual growth rate (CAGR) of 19.8%. This growth during the forecast period is fueled by factors such as the demand for drug development, a rise in preclinical testing, greater awareness of respiratory toxicology, an emphasis on regenerative medicine, increasing environmental concerns, and a growing geriatric population. Significant trends anticipated in this period involve an escalating demand for drug testing, ongoing advancements in 3D printing technology, progress in organ-on-chip technology, the incorporation of AI and machine learning, the integration of sensors and monitoring devices, an expansion of applications beyond pharmaceuticals, and the development of disease-specific models.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Which Factors Are Driving The Sarcoma Drugs Market Forward?

The future expansion of the in vitro lung model market is anticipated, propelled by an increase in clinical studies. These studies are research investigations designed to evaluate the effectiveness of novel medical interventions in human subjects. The surge in clinical studies is driven by an escalating demand for sophisticated medical treatments, growing healthcare needs, and the continuous pursuit of inventive solutions for intricate health challenges. In vitro lung models provide assistance in clinical trials by establishing a controlled environment for examining how various substances impact lung tissue, thereby facilitating drug evaluation, toxicity assessment, disease modeling, and the elucidation of disease mechanisms. For instance, in January 2024, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated that by the end of 2023, 477,230 clinical trials were registered globally on their platform, representing an increase compared to the 437,508 registered clinical trials in 2022. Consequently, the rising number of clinical studies serves as a driving force for the in vitro lung model market.

Which Segments Form The Key Structure Of The Sarcoma Drugs Market?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Strategic Shifts And Innovations Are Influencing The Sarcoma Drugs Market?

Leading companies active in the invitro lung model market are currently developing 3D respiratory tissue models to elevate their models’ physiological accuracy and intricacy. These 3D respiratory tissue models are crafted by cultivating specific respiratory cells within a controlled setting, allowing them to form a three-dimensional structure that emulates the respiratory system’s function and form, thus providing a more biologically pertinent platform for research and pharmaceutical testing. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, an inventive 3D respiratory tissue model constructed from primary human nasal epithelial cells. It accurately reproduces the three-dimensional framework and operational capabilities of nasal epithelium, including mucus-secreting goblet cells, robust tight junctions, and beating cilia. The introduction of EpiNasal broadens MatTek’s collection of 3D respiratory tissue models. This particular model furnishes a complete system for examining the impacts of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

Which Firms Are Making The Biggest Impact In The Sarcoma Drugs Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Is Expected To Lead The Sarcoma Drugs Market In The Next Few Years?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Browse Through More Reports Similar to the Global Sarcoma Drugs Market 2025, By The Business Research Company

In Vitro Diagnostics Ivd Quality Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

In Vitro Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

In Vitro Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model